Incidence and outcomes of invasive fungal disease in adult patients with acute lymphoblastic leukemia treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone: Implications for prophylaxis

Leukemia and Lymphoma

Volumn 54, Issue 6, 2013, Pages 1329-1331

  Henden, Andrea ^a   Morris, Kirk ^a   Truloff, Natasha ^a   Nakagaki, Midori ^a   Kennedy, Glen A ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUCONAZOLE; VINCRISTINE; VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIFUNGAL ACTIVITY; ASPERGILLUS NIGER; CANDIDA TROPICALIS; HUMAN; INFECTION PREVENTION; LETTER; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; SYSTEMIC MYCOSIS;

ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HUMANS; INCIDENCE; MYCOSES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TREATMENT OUTCOME; VINCRISTINE;

EID: 84877774811     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.740561     Document Type: Letter

References (14)

1. Hahn-Ast C, Glasmacher A, M ückter S, et al . Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006. J Antimicrob Chemother 2010; 65: 761- 768.
2. Ram R, Wolach O, Vidal L, et al . Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: Systematic review and meta-analysis . Am J Hematol 2012; 87 : 472 - 478.
3. De Pauw B, Walsh TJ, Donnelly JP, et al . Revised defi nitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) C on sensus Group. Clin Infect Dis 2008; 46 : 1813 - 1821.
4. Marr KA, Leisenring W, Crippa F, et al . Cyclophosphamide metabolism is aff ected by azole antifungals . Blood 2004; 103: 1557- 1559.
5. Harnicar S, Adel N, Jurcic J . Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients . J Oncol Pharm Pract 2009; 15: 175- 182.
6. Morris K, Weston H, Mollee P, et al . Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/ methotrexate, cytarabine:results from an Australian population . Leuk Lymphoma 2011; 52: 85- 91.
7. Hale KA, Shaw PJ, Dalla-Pozza L, et al . Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant . Br J Haematol 2010; 149 : 263 - 272.
8. Pagano L, Caira M, Candoni A, et al . The epidemiology of fungal infections in patients with hematologic malignancies:the SEIFEM- 2004 study . Haematologica 2006; 91 : 1068 - 1075.
9. Dignan FL, Evans SO, Ethell ME, et al . An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin fi rst line: An eff ective strategy with low mortality . Bone Marrow Transplant 2009; 44 : 51 - 56.
10. M ikolajewska A, S chwartz S, R uhnke M. A ntifungal treatment strategies in patients with haematological diseases or cancer:from prophylaxis to empirical, pre-emptive and targeted therapy. Mycoses 2012; 55 : 2 - 16.
11. Illmer T, Babatz J, Pursche S, et al . Posaconazole prophylaxis during induction therapy of patients with acute lymphoblastic leukaemia . Mycoses 2011; 54 : E143 - e147.
12. Fielding AK . How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia . Blood 2010; 116: 3409- 3417.
13. Cornely OA, Maertens J, Winston DJ, et al . Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348- 359.
14. Strevel EL, Ing DJ, Siu LL . Molecularly targeted oncology therapeutics and prolongation of the QT interval . J Clin Oncol 2007; 25 : 3362 - 3371.